EichorEICHOR
Condition: Active Idiopathic Inflammatory Myopathy Synced from ClinicalTrials.gov · August 05, 2026

Recruiting studies: Active Idiopathic Inflammatory Myopathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

OM336 in Seropositive Autoimmune Diseases
Phase 1 · 1 location(s) · Lakefront Biotherapeutics West LLC · NCT07229144A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie
Phase 3 · 146 location(s) · Pfizer · NCT05895786An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases
EARLY_Phase 1 · 1 location(s) · Shanghai Cell Therapy Group Co.,Ltd · NCT07174843Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
Phase 2 · 8 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07103746RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic I
Phase 2/Phase 3 · 35 location(s) · Cabaletta Bio · NCT06154252
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.